Schrödinger Suite of Tools

Accelerating innovation in drug discovery

Schrodinger logo

Schrödinger’s platform offers our scientists and members access to an extensive toolbox of sophisticated drug discovery technologies. This cutting-edge software is enabling our molecular innovation team to optimize molecular therapeutics and improve the effectiveness in targeting disease.

And, the computer simulations, property predictions and data management offered by Schrödinger, including the collaborative enterprise informatics platform LiveDesign, is transforming the way our scientists rapidly design and evaluate potential therapeutics.

Back to Scientific Resources.


Jay McGill, PhD
Chief Operating Officer and Executive Vice President of Administration

Woman sits holding young sick girl on her lap in hospital room.

Pediatric Rare Diseases Research

Over 90% of rare diseases have no FDA-approved treatments

“The primary way to treat neurofibromatosis 2 (NF2) hasn’t changed since I was in medical school. These kids, who live in our community, deserve more.”

D. Wade Clapp, MD
Chair of the Department of Pediatrics
Indiana University (IU) School of Medicine